Meeting
2021 ASCO Annual Meeting
Outcomes of allogeneic hematopoietic cell transplantation in patients with myelofibrosis: A systematic review and meta-analysis.
Authors
Jan Philipp Bewersdorf
Yale University School of Medicine, New Haven, CT
Jan Philipp Bewersdorf , Amar Sheth , Shaurey Vetsa , Alyssa Grimshaw , Smith Giri , Nikolai Alexandrovich Podoltsev , Lohith Gowda , Roni Tamari , Martin S. Tallman , Raajit Rampal , Amer Methqal Zeidan , Maximilian Stahl
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant
Track
Hematologic Malignancies
Sub Track
Myeloproliferative Neoplasms (MPN) and Mast Cell Disorders
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 7045)
DOI
10.1200/JCO.2021.39.15_suppl.7045
Abstract #
7045
Poster Bd #
Online Only
Abstract Disclosures
Funded by Conquer Cancer
Similar Posters
Poster
2022 ASCO Annual Meeting
Efficacy and safety of initial five years of adjuvant endocrine therapy in postmenopausal hormone receptor-positive breast cancer: A systematic review and network meta-analysis.
First Author: Hao Liao
Poster
2020 Genitourinary Cancers Symposium
Efficacy of adjuvant vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (VEGFRi) in renal cell carcinoma (RCC): A systematic review and meta-analysis.
First Author: Tobias Engel Ayer Botrel
Poster
2020 Genitourinary Cancers Symposium
A systematic review and network meta-analysis of FDA approved treatment options in men with nonmetastatic, castration-resistant prostate cancer (M0CRPC).
First Author: Irbaz Bin Riaz
Poster
2016 ASCO Annual Meeting
Long-term outcomes of ruxolitinib (RUX) therapy in patients (pts) with myelofibrosis (MF): 5-year update from COMFORT-I.
First Author: Vikas Gupta